The differential expression of TNF receptors and the subsequent activation of signaling cascades, such as NF-κB in lymphoid cells versus other pathways in myeloid cells, could underlie the selective predisposition to ALL. This evidence concerns the gene NFKB1 and acute lymphoblastic leukemia.